Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

3rd Feb 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Omega Diagnostics Group PLC, up 24% at 11.76 pence, 12-month range 6.50p-117.98p. The Alva, Scotland-based medical diagnostics company successfully attains a CE mark for its Visitect Covid-19 antigen test. "The company remains in discussions with commercial partners about how best to service the European market and other territories that recognise the CE mark. Omega's commercial offering will be via B2B partners and distributors, and not through a direct-to-consumer strategy," Omega adds.

----------

Creo Medical Group PLC, up 16% at 137.00 pence, 12-month range 116.50p-236.00p. The medical device company, with a focus on surgical endoscopy expects revenue for 2021 to top expectations at "just over" GBP25 million from GBP9.4 million in 2020.

----------

AIM - LOSERS

----------

Actual Experience PLC, down 15% at 12.90p, 12-month range 12.00p-135.00p. The Bath-based analytics-as-a-service company says its annual loss widens to GBP5.9 million in 2021 from GBP5.0 million in 2020. Revenue declines 11% to GBP1.7 million from GBP2.0 million. "Our sales team are engaged, directly or with partners, in multiple sales opportunities. Our clear focus in the coming months is to convert these opportunities to recurring 'continuous improvement' revenue streams," the company explains. Actual Experience accepts that shareholders have been "frustrated" with progress to date. "However, one of these lessons is that sales cycles will typically be longer than initially expected and therefore our planning has been adjusted to accommodate this timing," the company adds. Shares hit their 12-month low on Thursday.

----------

By Eric Cunha; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.


Related Shares:

Creo MedicalODX.LACT.L
FTSE 100 Latest
Value8,809.74
Change53.53